Pantoprazol Ametas (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Ametas, is a proton pump inhibitor presented as a 40 mg tablet for oral use. It reduces stomach acid production and is used to treat gastro‑reflux and other acid‑related disorders in adults. GNH USA supplies Pantoprazol Ametas as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazol Ametas is a proton pump inhibitor that acts on conditions characterised by excessive gastric acid secretion. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of erosive oesophagitis. - Peptic ulcer disease: supports ulcer healing and reduces risk of recurrence. - Zollinger‑Ellison syndrome: controls hyper‑secretion of gastric acid associated with the syndrome.

Pantoprazol Ametas may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild, occasional headache. - Diarrhea: loose stools without blood. - Nausea: mild nausea or upset stomach. - Abdominal pain: mild cramping or discomfort. - Flatulence: increased gas formation. - Constipation: infrequent bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhea, possibly with fever. - Low magnesium levels: muscle cramps, irregular heartbeat, or seizures. - Liver enzyme elevation: asymptomatic increase in liver function tests. - Fracture risk: potential reduction in bone mineral density with long‑term use. - Acute interstitial nephritis: kidney inflammation.

Pantoprazol Ametas should be used with caution: - Assess the risk of renal or hepatic impairment: t  t  t. - Monitor t t t  ....  etc…   etc…  ...   t  ....  ...

This     ---   t  ....  g  ....  ewline  ...